Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss? [Yahoo! Finance]
Viatris Inc. (VTRS)
Company Research
Source: Yahoo! Finance
other drug/generic companies due to report their first-quarter 2024 results this week. The majority of the large drugmakers have already reported their results. Many of these companies beat estimates for both earnings and sales. Some companies also raised their guidance for 2024, mainly the earnings per share outlook. Per the Zacks classification, the pharma/biotech industry comes under the broader Medical sector, which comprises pharma/biotech as well as medical device companies. As of May 1, per the Earnings Trends report, 55% of the companies in the Medical sector — representing 78.0% of the sector's market capitalization — reported quarterly earnings. Of these, 93.9% of participants beat estimates for earnings and 75.8% beat for revenues. While earnings declined 31.2% year over year, revenues rose 4.4% over the year-ago period. Overall, first-quarter earnings of the Medical sector are expected to decline 25.1%, while sales are expected to rise 7.1% year over year. Here w
Show less
Read more
Impact Snapshot
Event Time:
VTRS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTRS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTRS alerts
High impacting Viatris Inc. news events
Weekly update
A roundup of the hottest topics
VTRS
News
- Prevent Blindness Launches "It Started With an Eye Exam" Campaign to Encourage, Educate and Empower the Public to Make Vision and Eye Health a Part of Overall Health Care [Yahoo! Finance]Yahoo! Finance
- Viatris Inc. (NASDAQ:VTRS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
- Weak Sales From Lipitor, Norvasc Hurt Viatris' Q1 Earnings, Lowers Annual Forecast [Yahoo! Finance]Yahoo! Finance
- Viatris' (VTRS) Q1 Earnings & Sales Lag Estimates, Stock Down [Yahoo! Finance]Yahoo! Finance
VTRS
Earnings
- 5/9/24 - Miss
VTRS
Sec Filings
- 5/9/24 - Form 10-Q
- 5/9/24 - Form 8-K
- 4/26/24 - Form 10-K/A
- VTRS's page on the SEC website